Welcome to the Oncomine Blog
-
University of Munich Evaluates the Oncomine Comprehensive Plus Assay for HRD Detection
Our OncomineWorld event in 2021 brought thousands of professionals together from around the world to... -
Case Study: High-Quality, Cost-Effective Genomic Testing and Genetic Profiling using NGS
In a recent case study interview, pathologist Federico Jauk, head of the Sequencing Laboratory at th... -
Let’s Do It Ourselves - A global expert consensus is emerging: by retaining oncology biomarker testing in-house, healthcare management and patient care benefit significantly
Over the last decade, precision oncology therapies dependent on biomarker-based diagnostics have pro... -
A Comprehensive Answer for Cancer: Is Comprehensive Genomic Profiling Always the Right Approach?
What is comprehensive genomic profiling (CGP)? CGP is the simultaneous detection of all classes of g... -
Biomarker Tests for Precision Oncology: DIY or Pay-for-Service?
Cancer patient management of is increasingly driven by biomarker assays – but how should we manage t... -
What is Comprehensive Genomic Profiling & is it the Right Solution for You?
What is comprehensive genomic profiling? Comprehensive genomic profiling, or CGP, is the simultaneou... -
The Importance of Detecting Copy Number Variants (CNVs) in the Cancer Genome
Structural variants in the cancer genome Gene amplification (copy number gain) and deletion (copy nu... -
The OncomineWorld Experience from Behind the Curtain
BACKGROUND: There is little to no point in saying that we are all living in an unprecedented time, b... -
Comprehensive Biomarker Testing Reveals RET Alteration to Change Course of NSCLC Patient’s Treatment Options and Survival Outcome
It’s been a tough road for Melissa Crouse, sometimes almost deadly. She had a lobe of her left lung ...